Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study (vol 70, pg 526, 2009)

被引：0
|
作者：
Cutler, Andrew J.
机构：
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2009年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页码：1729 / 1729
页数：1
相关论文
共 50 条
  • [21] Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder
    Katila, Heikki
    Mezhebovsky, Irina
    Mulroy, Amy
    Berggren, Lovisa
    Eriksson, Hans
    Earley, Willie
    Datto, Catherine
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2013, 21 (08): : 769 - 784
  • [22] Efficacy of extended release Quetiapine Fumarate (Quetiapine XR) in patients with severe Major Depressive Disorder (MDD)
    Svedater, H.
    Thase, M.
    Locklear, J.
    Datto, C.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2009, 13 : 43 - 44
  • [23] Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder stratified by baseline anxiety level : Pooled analysis from two placebo-controlled trials
    Demyttenaere, K.
    Thase, M. E.
    Gustafsson, U.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 146 - 146
  • [24] EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION
    Thase, Michael E.
    Demyttenaere, Koen
    Earley, Willie R.
    Gustafsson, Urban
    Udd, Mattias
    Eriksson, Hans
    DEPRESSION AND ANXIETY, 2012, 29 (07) : 574 - 586
  • [25] Efficacy and tolerability of once-daily extended release Quetiapine Fumarate (Quetiapine XR) monotherapy in elderly patients with major depressive disorder (MDD)
    Katila, H.
    Mezhebovsky, I.
    Mulroy, A.
    Berggren, L.
    Datto, C.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 338
  • [26] ANALYSIS OF POOLED DATA: ONCE-DAILY EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) MONOTHERAPY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    Montgomery, S.
    Weisler, R.
    Earley, W.
    Astrom, M.
    Lazarus, A.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [27] Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study
    Merideth, Charles
    Cutler, Andrew J.
    She, Fahua
    Eriksson, Hans
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (01) : 40 - 54
  • [28] Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies
    Weisler, Richard H.
    Montgomery, Stuart A.
    Earley, Willie R.
    Szamosi, Johan
    Lazarus, Arthur
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (01) : 27 - 39
  • [29] POOLED ANALYSIS OF ADJUNCTIVE EXTENDED RELEASE QUETIAPINE FUMARATE (QUETIAPINE XR) IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER (MDD)
    El-Khalili, N.
    Bauer, M.
    Datto, C.
    Earley, W.
    Astrom, M.
    Eriksson, H.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [30] Once-daily extended release quetiapine fumarate (quetiapine xr) monotherapy in major depressive disorder (mdd): analysis in a subgroup of patients with anxious depression
    Demyttenaere, K.
    Thase, M.
    Earley, W.
    Astrom, M.
    Eriksson, H.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 348 - 349
12345